Aurinia Pharmaceuticals (AUPH) Non Operating Interest Expenses (2023 - 2026)
Aurinia Pharmaceuticals (AUPH) reported Non Operating Interest Expenses of $948,000 for Q2 2026, down 15.1% from $1.12 million a year earlier and down 6.3% from the prior quarter.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Non Operating Interest Expenses (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aurinia Pharmaceuticals' Non Operating Interest Expenses came in at $4.11 million, down 9.5% year-over-year; for FY2025, it came in at $4.33 million, down 10.4% from FY2024.
- By year, Non Operating Interest Expenses came in at $4.84 million in FY2024 (+74.2%) and $2.78 million in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Non Operating Interest Expenses since Q2 2023.
- Year over year, Non Operating Interest Expenses has now declined in each of the last eight quarters, with an average decline of 11.0% over the last eight quarters.
- The year-over-year decline in Non Operating Interest Expenses has ranged between 5.2% (Q1 2026) and 16.8% (Q1 2025) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.01 million (Q1 2026), $1.05 million (Q4 2025) and $1.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.15 Bn | 580.05 Mn | 76.67 Mn | 948,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 948,000.00 |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 65,000.00 |
API Access
Aurinia Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();